Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
1(10%)
Results Posted
63%(5 trials)

Phase Distribution

Ph phase_3
1
10%
Ph phase_1
3
30%
Ph not_applicable
2
20%
Ph phase_2
4
40%

Phase Distribution

3

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
3(30.0%)
Phase 2Efficacy & side effects
4(40.0%)
Phase 3Large-scale testing
1(10.0%)
N/ANon-phased studies
2(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(8)

Detailed Status

Completed8
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (30.0%)
Phase 24 (40.0%)
Phase 31 (10.0%)
N/A2 (20.0%)

Trials by Status

completed880%
recruiting110%
not_yet_recruiting110%

Recent Activity

1 active trials
Showing 5 of 10
recruitingphase_1

A Phase Ib Trial of Combined Febuxostat and Inosine Therapy in Patients With Parkinson's Disease

NCT07170475
completedphase_2

Inosine Reverse Chemo Resistance in Triple Negative Breast Cancer

NCT06355024
completednot_applicable

Inosine Energy Expenditure Study

NCT04476238
not_yet_recruitingnot_applicable

Therapeutic Antioxidant Supplementation

NCT04890808
completedphase_2

Safety of Urate Elevation in Amyotrophic Lateral Sclerosis (ALS)

NCT03168711
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT07170475Phase 1

A Phase Ib Trial of Combined Febuxostat and Inosine Therapy in Patients With Parkinson's Disease

Recruiting
NCT06355024Phase 2

Inosine Reverse Chemo Resistance in Triple Negative Breast Cancer

Completed
NCT04476238Not Applicable

Inosine Energy Expenditure Study

Completed
NCT04890808Not Applicable

Therapeutic Antioxidant Supplementation

Not Yet Recruiting
NCT03168711Phase 2

Safety of Urate Elevation in Amyotrophic Lateral Sclerosis (ALS)

Completed
NCT02642393Phase 3

Study of Urate Elevation in Parkinson's Disease, Phase 3

Completed
NCT02288091Phase 1

A Pilot Study of Inosine in Amyotrophic Lateral Sclerosis (ALS)

Completed
NCT02614469Phase 1

A Food-Drug Interaction Study of Serum Urate After Oral Inosine

Completed
NCT00833690Phase 2

Safety of Urate Elevation in Parkinson's Disease

Completed
NCT00067327Phase 2

Treatment of Multiple Sclerosis Using Over the Counter Inosine

Completed

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10